SECURITIES AND EXCHANGE COMMISSION
(Mark One)
| [X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| [ ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number 1-14279
ORBITAL SCIENCES CORPORATION
Delaware
|
06-1209561 | |
(State of Incorporation of Registrant)
|
(I.R.S. Employer Identification No.) |
21839 Atlantic Boulevard
Dulles, Virginia 20166
(Address of principal executive offices)
(703) 406-5000
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes [X] No [ ]
As of July 19, 2004, 49,230,103 shares of the registrants Common Stock were outstanding.
PART I
FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
ORBITAL SCIENCES CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
| June 30, | December 31, | |||||||
| 2004 |
2003 |
|||||||
| (unaudited) | ||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 105,842 | $ | 60,900 | ||||
Restricted cash and cash equivalents |
21,130 | 19,258 | ||||||
Receivables, net |
154,355 | 149,508 | ||||||
Inventories, net |
12,043 | 12,642 | ||||||
Other current assets |
3,303 | 5,496 | ||||||
Total current assets |
296,673 | 247,804 | ||||||
Property, plant and equipment, net |
80,229 | 82,364 | ||||||
Goodwill |
95,293 | 95,293 | ||||||
Other non-current assets |
12,143 | 13,839 | ||||||
Total assets |
$ | 484,338 | $ | 439,300 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Current portion of long-term obligations |
$ | 273 | $ | 297 | ||||
Accounts payable and accrued expenses |
131,653 | 116,026 | ||||||
Deferred revenues |
25,482 | 16,292 | ||||||
Total current liabilities |
157,408 | 132,615 | ||||||
Long-term obligations, net of current portion |
131,432 | 137,116 | ||||||
Other non-current liabilities |
1,657 | 2,692 | ||||||
Commitments and contingencies |
||||||||
Stockholders equity: |
||||||||
Preferred Stock, par value $.01; 10,000,000 shares authorized, none outstanding |
| | ||||||
Common Stock, par value $.01; 200,000,000 shares authorized, 49,312,659 and
48,072,580 shares outstanding, respectively |
493 | 480 | ||||||
Additional paid-in capital |
595,607 | 591,482 | ||||||
Deferred compensation |
(222 | ) | (502 | ) | ||||
Accumulated deficit |
(402,037 | ) | (424,583 | ) | ||||
Total stockholders equity |
193,841 | 166,877 | ||||||
Total liabilities and stockholders equity |
$ | 484,338 | $ | 439,300 | ||||
See accompanying notes to condensed consolidated financial statements.
1
ORBITAL SCIENCES CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, in thousands, except share data)
| For the Quarters Ended | ||||||||
| June 30, |
||||||||
| 2004 |
2003 |
|||||||
Revenues |
$ | 177,684 | $ | 158,400 | ||||
Costs of goods sold |
148,034 | 136,906 | ||||||
Gross profit |
29,650 | 21,494 | ||||||
Research and development expenses |
1,455 | 1,316 | ||||||
Selling, general and administrative expenses |
13,687 | 15,227 | ||||||
Settlement expense |
| 3,500 | ||||||
Income from operations |
14,508 | 1,451 | ||||||
Interest expense |
(2,889 | ) | (6,156 | ) | ||||
Other income, net |
227 | 79 | ||||||
Debt extinguishment expense |
(561 | ) | | |||||
Income (loss) before provision for income taxes |
11,285 | (4,626 | ) | |||||
Provision for income taxes |
(233 | ) | | |||||
Net income (loss) |
$ | 11,052 | $ | (4,626 | ) | |||
Basic net income (loss) per share |
$ | 0.23 | $ | (0.10 | ) | |||
Diluted net income (loss) per share |
$ | 0.17 | $ | (0.10 | ) | |||
See accompanying notes to condensed consolidated financial statements.
2
ORBITAL SCIENCES CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, in thousands, except share data)
| For the Six Months Ended | ||||||||
| June 30, |
||||||||
| 2004 |
2003 |
|||||||
Revenues |
$ | 329,056 | $ | 295,081 | ||||
Costs of goods sold |
274,488 | 247,353 | ||||||
Gross profit |
54,568 | 47,728 | ||||||
Research and development expenses |
3,197 | 2,898 | ||||||
Selling, general and administrative expenses |
25,196 | 29,492 | ||||||
Settlement expense |
(2,538 | ) | 4,500 | |||||
Income from operations |
28,713 | 10,838 | ||||||
Interest expense |
(5,798 | ) | (12,223 | ) | ||||
Other income, net |
653 | 195 | ||||||
Debt extinguishment expense |
(561 | ) | | |||||
Income (loss) before provision for income taxes |
23,007 | (1,190 | ) | |||||
Provision for income taxes |
(461 | ) | | |||||
Net income (loss) |
$ | 22,546 | $ | (1,190 | ) | |||
Basic net income (loss) per share |
$ | 0.47 | $ | (0.03 | ) | |||
Diluted net income (loss) per share |
$ | 0.34 | $ | (0.03 | ) | |||
See accompanying notes to condensed consolidated financial statements.
3
ORBITAL SCIENCES CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
| For the Six Months Ended | ||||||||
| June 30, |
||||||||
| 2004 |
2003 |
|||||||
Cash Flows From Operating Activities: |
||||||||
Net income (loss) |
$ | 22,546 | $ | (1,190 | ) | |||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
7,304 | 7,934 | ||||||
Amortization of debt issuance costs and debt discount |
467 | 3,627 | ||||||
Stock-based compensation and contributions to defined contribution plan |
(520 | ) | 3,661 | |||||
Debt extinguishment expense |
561 | | ||||||
Changes in assets and liabilities and other |
21,796 | 17,670 | ||||||
Net cash provided by operating activities |
52,154 | 31,702 | ||||||
Cash Flows From Investing Activities: |
||||||||
Capital expenditures |
(5,152 | ) | (4,167 | ) | ||||
Change in cash restricted for letters of credit, net |
(1,872 | ) | 8 | |||||
Net cash used in investing activities |
(7,024 | ) | (4,159 | ) | ||||
Cash Flows From Financing Activities: |
||||||||
Payments on long-term obligations |
(5,139 | ) | (965 | ) | ||||
Repurchase of common stock |
(2,000 | ) | | |||||
Net proceeds from issuances of common stock |
6,951 | 1,760 | ||||||
Net cash provided by (used in) financing activities |
(188 | ) | 795 | |||||
Net increase in cash and cash equivalents |
44,942 | 28,338 | ||||||
Cash and cash equivalents, beginning of period |
60,900 | 43,440 | ||||||
Cash and cash equivalents, end of period |
$ | 105,842 | $ | 71,778 | ||||
See accompanying notes to condensed consolidated financial statements.
4
ORBITAL SCIENCES CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2004 and 2003
(Unaudited)
(1) Basis of Presentation
Orbital Sciences Corporation (together with its subsidiaries, Orbital or the company), a Delaware corporation, develops and manufactures small space and rocket systems for commercial, military and civil government customers. The companys primary products are satellites and launch vehicles, including low-orbit, geosynchronous and planetary spacecraft for communications, remote sensing, scientific and defense missions; ground- and air-launched rockets that deliver satellites into orbit; and missile defense systems that are used as interceptor and target vehicles. Orbital also offers space-related technical services to government agencies and develops and builds satellite-based transportation management systems for public transit agencies and private vehicle fleet operators.
In the opinion of management, the accompanying unaudited interim financial information reflects all adjustments, consisting of normal recurring accruals, necessary for a fair presentation on a going concern basis. Certain information and footnote disclosure normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States have been condensed or omitted pursuant to instructions, rules and regulations prescribed by the Securities and Exchange Commission. The company believes that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited interim condensed consolidated financial statements are read in conjunction with the audited consolidated financial statements contained in the companys Annual Report on Form 10-K for the year ended December 31, 2003, as amended.
Operating results for the quarter and six months ended June 30, 2004 are not necessarily indicative of the results expected for the full year.
(2) Preparation of Condensed Consolidated Financial Statements
The preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions, including estimates of future contract costs and earnings. Such estimates and assumptions affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and earnings during the current reporting period. Management periodically assesses and evaluates the adequacy and/or deficiency of estimated liabilities recorded for various reserves, liabilities, contract risks and uncertainties. Actual results could differ from these estimates.
All financial amounts are stated in U.S. dollars unless otherwise indicated.
5
(3) Stock-Based Compensation
Statement of Financial Accounting Standards (SFAS) No. 123, Accounting for Stock-Based Compensation, as amended by SFAS No. 148, Accounting for Stock-Based Compensation Transition and Disclosure, an amendment of FASB Statement No. 123, requires companies to (i) recognize as expense the fair value of stock-based awards, or (ii) continue to apply the provisions of Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees and related interpretations (APB 25), and provide pro forma net income and earnings per share disclosures for employee stock option grants as if the fair-value-based method defined in SFAS No. 123 had been applied. The company continues to apply the provisions of APB 25 and provide the pro forma disclosures in accordance with the provisions of SFAS Nos. 123 and 148. Under APB 25, the company has not recorded any stock-based employee compensation cost associated with the companys stock option plan, as all options granted under the plan had an exercise price equal to the market value of the underlying common stock on the date of grant.
The company uses the Black-Scholes option-pricing model to determine the pro forma impact under SFAS Nos. 123 and 148 on the companys net income and earnings per share. The model utilizes certain information, such as the interest rate on a risk-free security maturing generally at the same time as the option being valued, and requires certain assumptions, such as the expected amount of time an option will be outstanding until it is exercised or it expires, to calculate the fair value of stock options granted. This information and the assumptions used for the quarterly and six-month periods ended June 30, 2004 and 2003 are summarized as follows:
| Quarters Ended June 30, |
||||||||
| 2004 |
2003 |
|||||||
Additional shares authorized for grant at June 30 |
430,073 | 1,402,532 | ||||||
Volatility |
65 | % | 67 | % | ||||
Risk-free interest rate |
3.10 | % | 1.61 | % | ||||
Weighted-average fair value per share at grant date |
$ | 4.92 | $ | 3.41 | ||||
Expected dividend yield |
| | ||||||
Expected life of options (years) |
2.5 | 4.5 | ||||||
| Six Months Ended June 30, |
||||||||
| 2004 |
2003 |
|||||||
Additional shares authorized for grant at June 30 |
430,073 | 1,402,532 | ||||||
Volatility |
65 | % | 67 | % | ||||
Risk-free interest rate |
3.06 | % | 1.68 | % | ||||
Weighted-average fair value per share at grant date |
$ | 4.96 | $ | 3.33 | ||||
Expected dividend yield |
| | ||||||
Expected life of options (years) |
2.5 4.5 | 4.5 | ||||||
6
The following table illustrates the effect on net income (loss) and earnings (loss) per share if the company had applied the fair value recognition provisions of SFAS No. 123 to its stock option plan (in thousands, except per share amounts):
| Quarters Ended June 30, |
||||||||
| 2004 |
2003 |
|||||||
Net income (loss), as reported |
$ | 11,052 | $ | (4,626 | ) | |||
Stock-based employee compensation expense per fair-value-based method |
(2,850 | ) | (1,264 | ) | ||||
Pro forma net income (loss) |
$ | 8,202 | $ | (5,890 | ) | |||
Earnings (loss) per share: |
||||||||
Basicas reported |
$ | 0.23 | $ | (0.10 | ) | |||
Basicpro forma |
$ | 0.17 | $ | (0.13 | ) | |||
Dilutedas reported |
$ | 0.17 | $ | (0.10 | ) | |||
Dilutedpro forma |
$ | 0.12 | $ | (0.13 | ) | |||
| Six Months Ended June 30, |
||||||||
| 2004 |
2003 |
|||||||
Net income (loss), as reported |
$ | 22,546 | $ | (1,190 | ) | |||
Stock-based employee compensation expense per fair-value-based method |
(4,040 | ) | (1,809 | ) | ||||
Pro forma net income (loss) |
$ | 18,506 | $ | (2,999 | ) | |||
Earnings (loss) per share: |
||||||||
Basicas reported |
$ | 0.47 | $ | (0.03 | ) | |||
Basicpro forma |
$ | 0.38 | $ | (0.07 | ) | |||
Dilutedas reported |
$ | 0.34 | $ | (0.03 | ) | |||
Dilutedpro forma |
$ | 0.28 | $ | (0.07 | ) | |||
Pro forma net income (loss) reflects only options granted through June 30, 2004 and, therefore, may not be representative of the effects for future periods.
(4) Industry Segment Information
Orbitals space-related products and services are grouped into three reportable segments: (i) launch vehicles (formerly launch vehicles and advanced programs), (ii) satellites and related space systems and (iii) transportation management systems. Reportable segments are generally organized based upon product lines. Corporate and other is comprised of the elimination of intercompany revenues and certain corporate expenses that have not been attributed to a particular segment.
Intersegment sales are generally negotiated and accounted for under terms and conditions that are similar to other commercial and government contracts. Intersegment sales of $2.6 million and $1.6 million were recorded in the quarters ended June 30, 2004 and 2003, respectively. Intersegment sales of $4.5 million and $3.2 million were recorded in the six months ended June 30, 2004 and 2003, respectively.
7
The following table presents operating information for the quarters and six months ended June 30, 2004 and 2003 and identifiable assets at June 30, 2004 and December 31, 2003 by reportable segment (in thousands):
| Quarters Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Launch Vehicles: |
||||||||||||||||
Revenues |
$ | 86,508 | $ | 85,166 | $ | 162,997 | $ | 165,705 | ||||||||
Operating income |
7,220 | 8,552 | 14,123 | 17,780 | ||||||||||||
Identifiable assets |
127,446 | 126,960 | 127,446 | 126,960 | ||||||||||||
Capital expenditures |
600 | 1,163 | 1,593 | 2,128 | ||||||||||||
Depreciation and amortization |
1,295 | 1,537 | 2,630 | 2,926 | ||||||||||||
Satellites and Related Space Systems: |
||||||||||||||||
Revenues |
$ | 85,823 | $ | 68,878 | $ | 155,204 | $ | 117,389 | ||||||||
Operating income |
6,980 | 3,182 | 11,434 | 5,851 | ||||||||||||
Identifiable assets |
162,666 | 149,933 | 162,666 | 149,933 | ||||||||||||
Capital expenditures |
1,401 | 387 | 2,662 | 790 | ||||||||||||
Depreciation and amortization |
1,302 | 1,432 | 2,568 | 2,868 | ||||||||||||
Transportation Management Systems: |
||||||||||||||||
Revenues |
$ | 7,984 | $ | 5,999 | $ | 15,315 | $ | 15,204 | ||||||||
Operating income (loss) |
308 | (6,783 | ) | 618 | (8,293 | ) | ||||||||||
Identifiable assets |
26,829 | 37,596 | 26,829 | 37,596 | ||||||||||||
Capital expenditures |
69 | 189 | 148 | 204 | ||||||||||||
Depreciation and amortization |
185 | 195 | 383 | 393 | ||||||||||||
Corporate and Other: |
||||||||||||||||
Revenues |
$ | (2,631 | ) | $ | (1,643 | ) | $ | (4,460 | ) | $ | (3,217 | ) | ||||
Operating income (loss) |
| (3,500 | ) | 2,538 | (4,500 | ) | ||||||||||
Identifiable assets |
167,397 | 124,811 | 167,397 | 124,811 | ||||||||||||
Capital expenditures |
454 | 768 | 749 | 1,045 | ||||||||||||
Depreciation and amortization |
870 | 877 | 1,723 | 1,747 | ||||||||||||
Consolidated: |
||||||||||||||||
Revenues |
$ | 177,684 | $ | 158,400 | $ | 329,056 | $ | 295,081 | ||||||||
Operating income |
14,508 | 1,451 | 28,713 | 10,838 | ||||||||||||
Identifiable assets |
484,338 | 439,300 | 484,338 | 439,300 | ||||||||||||
Capital expenditures |
2,524 | 2,507 | 5,152 | 4,167 | ||||||||||||
Depreciation and amortization |
3,652 | 4,041 | 7,304 | 7,934 | ||||||||||||
(5) Receivables
Receivables consisted of the following (in thousands):
| June 30, 2004 |
December 31, 2003 |
|||||||
Billed |
$ | 51,340 | $ | 55,812 | ||||
Unbilled |
103,203 | 93,883 | ||||||
Allowance for doubtful accounts |
(188 | ) | (187 | ) | ||||
Total |
$ | 154,355 | $ | 149,508 | ||||
8
(6) Inventories
Inventories consisted of the following (in thousands):
| June 30, 2004 |
December 31, 2003 |
|||||||
Inventories |
$ | 14,940 | $ | 15,475 | ||||
Allowance for inventory obsolescence |
(2,897 | ) | (2,833 | ) | ||||
Total |
$ | 12,043 | $ | 12,642 | ||||
Substantially all of the companys inventory consisted of component parts and raw materials.
(7) Warranties
The company assumes warranty obligations in connection with certain contracts. The company records a liability for estimated warranty claims based upon historical data and customer information. Activity in the warranty liability consisted of the following (in thousands):
| Quarter Ended | Quarter Ended | |||||||
| June 30, 2004 |
June 30, 2003 |
|||||||
Balance at beginning of period |
$ | 4,665 | $ | 4,922 | ||||
Accruals during the period |
259 | 257 | ||||||
Charges incurred during the period |
(584 | ) | (411 | ) | ||||
Balance at end of period |
$ | 4,340 | $ | 4,768 | ||||
| Six Months Ended | Six Months Ended | |||||||
| June 30, 2004 |
June 30, 2003 |
|||||||
Balance at beginning of period |
$ | 5,020 | $ | 4,554 | ||||
Accruals during the period |
338 | 926 | ||||||
Charges incurred during the period |
(1,018 | ) | (712 | ) | ||||
Balance at end of period |
$ | 4,340 | $ | 4,768 | ||||
(8) Interest Expense
Interest expense consisted of the following (in thousands):
| Quarters Ended | Six Months Ended | |||||||||||||||
| June 30, |
June 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Interest |
$ | 2,656 | $ | 4,301 | $ | 5,331 | $ | 8,596 | ||||||||
Amortization of debt issuance costs |
233 | 718 | 467 | 1,412 | ||||||||||||
Amortization of debt discount |
| 1,137 | | 2,215 | ||||||||||||
Total |
$ | 2,889 | $ | 6,156 | $ | 5,798 | $ | 12,223 | ||||||||
9
(9) Earnings Per Share
The following table presents the shares used in computing basic and diluted earnings per share (EPS) (in thousands):
| Quarter Ended | Quarter Ended | |||||||
| June 30, 2004 |
June 30, 2003 |
|||||||
Weighted average of outstanding shares for basic EPS |
48,764 | 46,392 | ||||||
Dilutive effect of outstanding stock options and warrants |
17,008 | | ||||||
Shares for diluted EPS |
65,772 | 46,392 | ||||||
| Six Months Ended | Six Months Ended | |||||||
| June 30, 2004 |
June 30, 2003 |
|||||||
Weighted average of outstanding shares for basic EPS |
48,405 | 46,074 | ||||||
Dilutive effect of outstanding stock options and warrants |
17,154 | | ||||||
Shares for diluted EPS |
65,559 | 46,074 | ||||||
(10) Comprehensive Income (Loss)
Comprehensive income (loss) in the quarterly and six-month periods ended June 30, 2004 and 2003 was equal to net income (loss). Accumulated other comprehensive income as of June 30, 2004 and December 31, 2003 was $0.
(11) Sale of ORBIMAGE Notes
On December 31, 2003, Orbital received $2.5 million of senior subordinated notes due 2008 from its former affiliate, Orbital Imaging Corporation (ORBIMAGE). Orbital received these notes upon the consummation of ORBIMAGEs plan of reorganization as stipulated by a February 2003 settlement agreement. In 2003, Orbital recorded $4.8 million of charges, including $4.5 million in the first half of 2003, in connection with the settlement agreement. In the first quarter of 2004, the company sold the notes to a financial institution and recorded a $2.5 million gain on this transaction as a credit to settlement expense. Orbital does not have any equity or debt investment in ORBIMAGEs successor company.
(12) Debt
The following table sets forth the companys long-term obligations, excluding capital lease obligations (in thousands):
| June 30, 2004 |
December 31, 2003 |
|||||||
9% senior notes, interest due semi-annually, principal due in July 2011 |
$ | 130,424 | $ | 135,000 | ||||
Interest rate swap fair value hedge adjustment on $50 million of 9%
Senior Notes |
862 | 1,847 | ||||||
| 131,286 | 136,847 | |||||||
Less current portion |
| | ||||||
Long-term portion |
$ | 131,286 | $ | 136,847 | ||||
During the second quarter of 2004, the company repurchased $4.6 million of its 9% senior notes under a securities repurchase program.
10
The fair value of the companys senior notes at June 30, 2004 and December 31, 2003 was estimated at approximately $143.5 million and $145.1 million, respectively, based on market trading activity.
The company has a $50.0 million four-year revolving credit facility (the Revolver) with Bank of America serving as the lead arranger in a syndicated line of credit. The Revolver bears interest at rates ranging from 2.25% to 3.0% over LIBOR (for LIBOR loans) or from 0.75% to 1.5% over a base rate related to the prime rate (for base rate loans), varying according to the companys ratio of total debt to earnings before interest, taxes, depreciation and amortization. The Revolver is collateralized by substantially all of the companys assets. The Revolver also permits the company to reserve up to $40.0 million of the facility for letters of credit, foreign exchange contracts or other arrangements. The maximum borrowing capacity under the Revolver is limited by a borrowing base formula that is tied to the companys billed accounts receivable balance. As of June 30, 2004, there were no borrowings under the Revolver, although $6.4 million of standby letters of credit were issued under the Revolver. As of June 30, 2004, $43.6 million of the Revolver was available for borrowing.
The senior notes and the Revolver contain covenants limiting the companys ability to, among other things, incur more debt, redeem or repurchase Orbital stock, enter into transactions with affiliates, merge or consolidate with others and dispose of assets or create liens on assets. The Revolver contains an absolute prohibition and the senior notes contain restrictions on the payment by the company of cash dividends. In addition, the Revolver contains financial covenants with respect to leverage, secured leverage, minimum cash balance, fixed charge coverage and consolidated net worth. As of June 30, 2004, the company was in compliance with all of these covenants.
In 2003, the company entered into an eight-year interest rate swap agreement with a financial institution on a notional amount of $50.0 million, whereby the company receives fixed-rate interest of 9% in exchange for variable interest payments. The interest rate is reset quarterly and is equal to the 3-month LIBOR rate plus 4.28%. The total variable interest rate was 5.42% at June 30, 2004. This arrangement has been designated an effective fair value hedge of $50.0 million of the companys senior notes. As of June 30, 2004 and December 31, 2003, the fair value of the interest rate swap was $0.9 million and $1.8 million, respectively, which was recorded in other non-current assets with an equal fair value adjustment recorded on $50.0 million of the senior notes.
(13) Commitments and Contingencies
Contracts
Most of the companys government contracts are funded incrementally on a year-to-year basis. Changes in government policies, priorities or funding levels through agency or program budget reductions by the U.S. Congress or executive agencies could materially adversely affect the companys financial condition or results of operations. Furthermore, contracts with the U.S. government may be terminated or suspended by the U.S. government at any time, with or
11
without cause. Such contract suspensions or terminations could result in unreimbursable expenses or charges or otherwise adversely affect the companys financial condition and/or results of operations.
Litigation
The company is party to certain litigation or other legal proceedings arising in the ordinary course of business. In the opinion of management, the outcome of such legal matters will not have a material adverse effect on the companys results of operations or financial condition.
Other Contingencies
In 2003, the company suspended work and revenue recognition on a transportation management systems contract as a result of the customers inability to provide equipment necessary to complete the contract. The contract is currently being renegotiated. As of both June 30, 2004 and December 31, 2003, the companys balance sheet included total receivables and inventory of approximately $3.0 million related to this contract. Although the company believes that these assets are realizable, there can be no assurance that the final outcome of the negotiations will not impact the realizability of the assets.
12
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
With the exception of historical information, the matters discussed below under the headings Consolidated Results of Operations for the Quarters and Six Months Ended June 30, 2004 and 2003, Segment Results, Backlog, Liquidity and Capital Resources and elsewhere in this report on Form 10-Q include forward-looking statements that involve risks and uncertainties, many of which are beyond our control. A number of important factors, including those identified in our Annual Report on Form 10-K for the year ended December 31, 2003, as amended, may affect our actual results and may cause actual results to differ materially from those anticipated or expected in any forward-looking statement. We assume no obligation to update any forward-looking statements.
We develop and manufacture small space and rocket systems for commercial, military and civil government customers. Our primary products are satellites and launch vehicles, including low-orbit, geosynchronous and planetary spacecraft for communications, remot